GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (XTER:1SXP) » Definitions » Interest Expense

Schott Pharma AG KGaA (XTER:1SXP) Interest Expense : €-15.7 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Schott Pharma AG KGaA Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Schott Pharma AG KGaA's interest expense for the three months ended in Dec. 2024 was € -4.8 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was €-15.7 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Schott Pharma AG KGaA's Operating Income for the three months ended in Dec. 2024 was € 35.8 Mil. Schott Pharma AG KGaA's Interest Expense for the three months ended in Dec. 2024 was € -4.8 Mil. Schott Pharma AG KGaA's Interest Coverage for the quarter that ended in Dec. 2024 was 7.45. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Schott Pharma AG KGaA Interest Expense Historical Data

The historical data trend for Schott Pharma AG KGaA's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA Interest Expense Chart

Schott Pharma AG KGaA Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24
Interest Expense
-1.92 -1.67 -2.69 -7.25 -13.49

Schott Pharma AG KGaA Quarterly Data
Sep20 Sep21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.55 -2.91 -3.66 -4.36 -4.80

Schott Pharma AG KGaA Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-15.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Schott Pharma AG KGaA  (XTER:1SXP) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Schott Pharma AG KGaA's Interest Expense for the three months ended in Dec. 2024 was €-4.8 Mil. Its Operating Income for the three months ended in Dec. 2024 was €35.8 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was €0.0 Mil.

Schott Pharma AG KGaA's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Dec. 2024 )/Interest Expense (Q: Dec. 2024 )
=-1*35.792/-4.802
=7.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Schott Pharma AG KGaA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (XTER:1SXP) » Definitions » Interest Expense
Comparable Companies
XTER:FIE XTER:AFX XTER:GXI ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN COO BAX WST ALGN HOLX NZSE:FPH SOLV
Traded in Other Exchanges
SHTPY:USA 1SXPd:UK 1SXP:Austria
Address
Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Website
https://www.schott-pharma.com
Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.
Executives
Dr. Jens Schulte Supervisory Board
Andreas Reisse Board of Directors
Ann-kristin Erkens Supervisory Board
Dr. Almuth Steinkühler Board of Directors
Dr. Wolfgang Wienand Supervisory Board
Peter Goldschmidt Supervisory Board

Schott Pharma AG KGaA Headlines

No Headlines